Mr Dirk Strauss

Profile: Mr Dirk Strauss — Consultant Surgical Oncologist & Sarcoma Specialist

Mr Dirk Strauss is an experienced Consultant Surgical Oncologist internationally recognised for his extensive expertise in the management of soft‑tissue sarcomas.

With a career dedicated to the treatment of rare and complex cancers, he has established himself as a leading figure in the field of sarcoma surgery, delivering operative care grounded in evidence‑based practice and multidisciplinary collaboration.

Surgical Expertise in Sarcoma and Complex Oncologic Resections

Mr Strauss specialises in complex oncologic resections, including the management of all soft‑tissue sarcomas, retroperitoneal sarcomas, and advanced trunk and abdominal wall or limb tumours requiring surgical management.

He is permanently based at The Royal Marsden Hospital, where he works within the Sarcoma and Melanoma Unit. His reputation for technical excellence makes him a sought‑after surgeon for cases requiring nuanced judgement and thorough experience with the biological behaviour of sarcoma subtypes.

Leadership in National and International Guideline Development

Beyond his surgical practice, Mr Strauss is a respected contributor to the development of sarcoma management standards. He has been an active participant in both national and international guideline‑setting initiatives, helping shape contemporary best practice for a rare and diverse group of malignancies.

His contributions include:

· Participation in national sarcoma guideline committees, working with multidisciplinary experts to update clinical pathways and promote consistent, high‑quality care across specialist centres.

· Engagement with international sarcoma organisations, providing surgical insight to collaborative guideline projects and consensus statements that influence global care frameworks.

· Advocacy for evidence‑based treatment, ensuring that surgical recommendations reflect the latest research, emerging therapies, and evolving understanding of sarcoma biology. He is the UK Principal Investigator for the STRASS 2 (EORTC 1809-STBSG) clinical trial and is on the Executive committee of the Transatlantic Australasian Retroperitoneal Sarcoma Working Group and part of the team collaborating with The Institute of Cancer Research.

· Educational leadership, presenting guideline updates at conferences, training  programmes, and tumour boards to support dissemination and implementation across clinical communities.

A Commitment to Multidisciplinary Excellence

Mr Strauss is deeply committed to multidisciplinary cancer care. He works closely with medical oncology, radiation oncology, radiology, pathology, and specialist sarcoma teams to ensure each patient receives an individualised, carefully coordinated treatment plan. His collaborative philosophy and patient‑centred approach are hallmarks of his practice.